Danuglutide vs Liraglutide

Danuglutide is an experimental GLP-1 drug still in development, while liraglutide (sold as Saxenda or Victoza) is an FDA-approved GLP-1 treatment. Liraglutide is approved for type 2 diabetes, obesity, and reducing cardiovascular risk, whereas danuglutide has no approved uses yet. Both work the same way by acting as GLP-1 receptor agonists, but liraglutide is already on the market, while danuglutide remains in clinical trials.

AI summary of the sources below.